) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2023 Reviewed Company Q3 30/11/2022 2023 Reviewed Consolidated Q3 30/11/2022 2023 Reviewed
Company Q3 30/11/2024 2025 Reviewed Consolidated Q3 30/11/2024 2025 Reviewed Consolidated Q2 31/08/2024 2025 Reviewed Company Q2 31/08/2024 2025 Reviewed Consolidated Q1 31/05/2024
, the total transaction value shall be equivalent to 39.91% calculated based on the Net Profit which is the basis that results in the highest transaction value, from the Consolidated Financial Statement
million o The annual general meeting of the BCP Innovation Pte .Ltd. approved a resolution to increase its registered capital from USD 42 million (attributed to 42 million shares, valued at USD 1 per share
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021